Hemojuvelin: A supposed role in iron metabolism one year after its discovery

Journal of Molecular Medicine

Volumn 83, Issue 7, 2005, Pages 521-525

  Celec, Peter ^a,b,c  

^a BiomeD Research and Publishing Group   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c NONE   (Slovakia)

Author keywords

Hemojuvelin; Hepcidin; HFE; Iron metabolism; Juvenile hemochromatosis

Indexed keywords

HEMOJUVELIN; HEPCIDIN; HFE PROTEIN; IRON; PROTEIN DERIVATIVE; REGULATOR PROTEIN; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR 2; UNCLASSIFIED DRUG;

ANEMIA; CLINICAL RESEARCH; COMPLEX FORMATION; COMPREHENSION; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE MUTATION; GENETIC DISORDER; HEMOCHROMATOSIS; HORMONAL REGULATION; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INTESTINE CELL; IRON ABSORPTION; IRON KINETICS; IRON METABOLISM; JUVENILE; MACROPHAGE; MOLECULAR MECHANICS; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTE; PROTEIN EXPRESSION; REVIEW; SEQUENCE HOMOLOGY; TARGET CELL;

ANIMALS; HEMOCHROMATOSIS; HUMANS; IRON; MEMBRANE PROTEINS;

EID: 23744489877     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-005-0668-y     Document Type: Review

References (40)

1. De Gobbi M, Roetto A, Piperno A, Mariani R, Alberti F, Papanikolaou G, Politou M, Lockitch G, Girelli D, Fargion S, Cox TM, Gasparini P, Cazzola M, Camaschella C (2002) Natural history of juvenile haemochromatosis. Br J Haematol 117:973-979
2. Pietrangelo A (2004) Non-HFE hemochromatosis. Hepatology 39:21-29
3. Roetto A, Totaro A, Cazzola M, Cicilano M, Bosio S, D'Ascola G, Carella M, Zelante L, Kelly AL, Cox TM, Gasparini P, Camaschella C (1999) Juvenile hemochromatosis locus maps to chromosome 1q. Am J Hum Genet 64:1388-1393
4. Rivard SR, Lanzara C, Grimard D, Carella M, Simard H, Ficarella R, Simard R, D'Adamo AP, Ferec C, Camaschella C, Mura C, Roetto A, De Braekeleer M, Bechner L, Gasparini P (2003) Juvenile hemochromatosis locus maps to chromosome 1q in a French Canadian population. Eur J Hum Genet 11:585-589
5. Roetto A, Alberti F, Daraio F, Cali A, Cazzola M, Totaro A, Gasparini P, Camaschella C (2000) Exclusion of ZIRTL as candidate gene of juvenile hemochromatosis and refinement of the critical interval on 1q21. Blood Cells Mol Dis 26:205-210
6. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, Goldberg YP (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36:77-82
7. Brissot P, Troadec MB, Loreal O (2004) The clinical relevance of new insights in iron transport and metabolism. Curr Hematol Rep 3:107-115
8. Griffiths W, Cox T (2000) Haemochromatosis: novel gene discovery and the molecular pathophysiology of iron metabolism. Hum Mol Genet 9:2377-2382
9. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408
10. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211-218
11. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J, Fei Y, Brunt EM, Ruddy DA, Prass CE, Schatzman RC, O'Neill R, Britton RS, Bacon BR, Sly WS (1998) HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A 95:2492-2497
12. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480:147-150
13. Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806-7810
14. Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S (2002) Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 29:327-335
15. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093
16. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101:2461-2463
17. Delatycki MB, Allen KJ, Gow P, MacFarlane J, Radomski C, Thompson J, Hayden MR, Goldberg YP, Samuels ME (2004) A homozygous HAMP mutation in a multiply consanguineous family with pseudo-dominant juvenile hemochromatosis. Clin Genet 65:378-383
18. Matthes T, Aguilar-Martinez P, Pizzi-Bosman L, Darbellay R, Rubbia-Brandt L, Giostra E, Michel M, Ganz T, Beris P (2004) Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5′-UTR of the HAMP gene. Blood 104:2181-2183
19. Rodriguez Martinez A, Niemela O, Parkkila S (2004) Hepatic and extrahepatic expression of the new iron regulatory protein hemojuvelin. Haematologica 89:1441-1445
20. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C (2005) Hepcidin is decreased in TFR2 hemochromatosis. Blood 105:1803-1806
21. Robson KJ, Merryweather-Clarke AT, Cadet E, Viprakasit V, Zaahl MG, Pointon JJ, Weatherall DJ, Rochette J (2004) Recent advances in understanding haemochromatosis: a transition state. J Med Genet 41:721-730
22. Camaschella C, Roetto A, De Gobbi M (2002) Juvenile hemochromatosis. Semin Hematol 39:242-248
23. Lee PL, Barton JC, Brandhagen D, Beutler E (2004) Hemojuvelin (HJV) mutations in persons of European, African-American and Asian ancestry with adult onset haemochromatosis. Br J Haematol 127:224-229
24. Biasiotto G, Roetto A, Daraio F, Polotti A, Gerardi GM, Girelli D, Cremonesi L, Arosio P, Camaschella C (2004) Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol Dis 33:338-343
25. Lanzara C, Roetto A, Daraio F, Rivard S, Ficarella R, Simard H, Cox TM, Cazzola M, Piperno A, Gimenez-Roqueplo AP, Grammatico P, Volinia S, Gasparini P, Camaschella C (2004) Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 103:4317-4321
26. Lee PL, Beutler E, Rao SV, Barton JC (2004) Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. Blood 103:4669-4671
27. Barton JC, Rivers CA, Niyongere S, Bohannon SB, Acton RT (2004) Allele frequencies of hemojuvelin gene (HJV) I222N and G320V missense mutations in white and African American subjects from the general Alabama population. BMC Med Genet 5:29
28. Huang FW, Rubio-Aliaga I, Kushner JP, Andrews NC, Fleming MD (2004) Identification of a novel mutation (C321X) in HJV. Blood 104:2176-2177
29. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21-22
30. de Sousa M, Porto G (1998) The immunological system in hemochromatosis. J Hepatol 28(Suppl 1):1-7
31. Robb A, Wessling-Resnick M (2004) Regulation of transferrin receptor 2 protein levels by transferrin. Blood 104:4294-4299
32. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C (2005) Hepcidin is decreased in TFR2-hemochromatosis. Blood 105:1803-1806
33. Kawabata H, Fleming RE, Gui D, Moon SY, Saitoh T, O'Kelly J, Umehara Y, Wano Y, Said JW, Koeffler HP (2005) Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 105:376-381
34. Nisbet-Brown E (2004) Hemojuvelin and hepcidin: the keys to JH? Blood 104:1918-1919
35. Ajioka R, Kushner J (2004) Another link in the chain. Blood 103:2439-2440
36. Roy CN, Custodio AO, de Graaf J, Schneider S, Akpan I, Montross LK, Sanchez M, Gaudino A, Hentze MW, Andrews NC, Muckenthaler MU (2004) An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide- induced inflammation in mice. Nat Genet 36:481-485
37. Ludwiczek S, Aigner E, Theurl I, Weiss G (2003) Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 101:4148-4154
38. Nicolas G, Viatte L, Lou DQ, Bennoun M, Beaumont C, Kahn A, Andrews NC, Vaulont S (2003) Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 34:97-101
39. Krijt J, Vokurka M, Chang KT, Necas E (2004) Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin. Blood 104:4308-4310
40. Gasparini P, Camaschella C (2004) Hereditary hemochromatosis: is the gene race over? Eur J Hum Genet 12:341-342